Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95,824 | -67,630 | -41,621 | -18,348 | -53,575 |
| Depreciation Amortization | 4,054 | 2,926 | 1,805 | 793 | 1,494 |
| Accounts payable and accrued liabilities | -1,848 | -4,140 | -3,562 | -4,938 | N/A |
| Other Working Capital | -2,797 | -3,623 | -3,100 | -4,949 | 4,862 |
| Other Operating Activity | 7,413 | 7,816 | 5,810 | 5,263 | 5,950 |
| Operating Cash Flow | $-89,002 | $-64,651 | $-40,668 | $-22,179 | $-41,269 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -253,368 | -249,487 | -118,169 | -117,150 | N/A |
| PPE Investments | -44,970 | -28,249 | -12,513 | -1,884 | -9,825 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -4,722 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -8,210 |
| Investing Cash Flow | $-298,338 | $-277,736 | $-130,682 | $-119,034 | $-22,757 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,518 | 2,412 | 2,402 | 185 | N/A |
| Other Financing Activity | 415,256 | 415,256 | 415,732 | 193,300 | 47,690 |
| Financing Cash Flow | $417,774 | $417,668 | $418,134 | $193,485 | $47,690 |
| Beginning Cash Position | 27,728 | 27,728 | 27,728 | 27,728 | 44,064 |
| End Cash Position | 58,162 | 103,009 | 274,512 | 80,000 | 27,728 |
| Net Cash Flow | $30,434 | $75,281 | $246,784 | $52,272 | $-16,336 |
| Free Cash Flow | |||||
| Operating Cash Flow | -89,002 | -64,651 | -40,668 | -22,179 | -41,269 |
| Capital Expenditure | -44,970 | -28,249 | -12,513 | -1,884 | N/A |
| Free Cash Flow | -133,972 | -92,900 | -53,181 | -24,063 | -41,269 |